Calendar Navidea Biopharmaceuticals, Inc.

Equities

Market Closed - OTC Markets Other stock markets 13:08:31 2024-04-26 EDT			5-day change	1st Jan Change
0.0381 ^USD	+1.33%		+8.86%	-30.98%

2023	Navidea Biopharmaceuticals, Inc. announced that it expects to receive $0.75 million in funding	CI
2023	Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

b415a10.JrIrB8HZFL0sk8-KwDSJTvlhWYSZcPMaW8OzwNoobOc.fuNpSfSvRupDw7nm83u_IpsOG-n1NIRjHYj0hp5tJZFq1mlWtuAkhFvAvA~616c0c299f57c7950a7771634ea67ff2

2024-05-06	Q1 2024 Earnings Release (Projected)
2024-08-06	Q2 2024 Earnings Release (Projected)
2024-11-05	Q3 2024 Earnings Release (Projected)

2023-11-16 13:00	Annual General Meeting
2023-11-13	Q3 2023 Earnings Release
2023-07-27 13:00	Extraordinary Shareholders Meeting
2023-06-07 16:00	Q1 2023 Earnings Release
2023-03-21 17:00	Q4 2022 Earnings Call
2023-03-21 16:01	Q4 2022 Earnings Release
2022-12-08 13:00	Annual General Meeting
2022-11-15 17:00	Q3 2022 Earnings Call
2022-11-14 08:00	Q3 2022 Earnings Release
2022-11-10 09:00	Annual Meeting of the Society for Immunotherapy of Cancer - Abstract #1161
2022-11-09	American College of Rheumatology Convergence Conference
2022-09-08 16:00	Interim 2022 Earnings Call
2022-08-15 08:30	Interim 2022 Earnings Release
2022-06-11 21:00	Society of Nuclear Medicine and Molecular Imaging Meeting - Abstract No-197
2022-05-12 17:00	Q1 2022 Earnings Call
2022-05-12 07:30	Q1 2022 Earnings Release
2022-04-20 17:00	NAV3-32 Phase 2B Study Results Call
2022-04-14 17:00	Business Update Call
2022-03-23 17:00	FY 2021 Earnings Call
2022-03-23 07:30	FY 2021 Earnings Release

Fiscal Period	December	2018	2019	2020
Net sales Million USD	Released Forecast Spread	1,17	0,66 0,77 -14.18%	0,92 0,90 2.18%
EBITDA	Released Forecast Spread	0,00	0,00 0,00 -	0,00 0,00 -
EBIT Million USD	Released Forecast Spread	0,00	-11,0 -11,0 0.09%	-10,7 -12,1 11.2%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	0,00	-10,9 -11,0 0.17%	-10,7 -12,1 11.02%
Net income Million USD	Released Forecast Spread	0,00	-10,9 -11,0 0.16%	-11,4 -12,1 5.51%
EPS USD	Released Forecast Spread	-1,80	-0,76 -0,74 -3.4%	-0,48 -0,48 0%
Announcement Date		-	11/03/20	24/03/21

Fiscal Period	December	2021 Q3
Net sales Million USD	Released Forecast Spread	0,10 0,00 -
EBIT Million USD	Released Forecast Spread	-2,42 -3,52 31.26%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-2,42 -3,52 31.26%
Net income Million USD	Released Forecast Spread	-2,44 -3,52 30.8%
EPS USD	Released Forecast Spread	-0,08 -0,11 27.27%
Announcement Date		10/11/21

2024-04-28	BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28	SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
2024-04-28	JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
2024-04-28	MORPHOSYS AG: Q1 2024 Earnings Release
2024-04-29 16:05	QIAGEN N.V.: Q1 2024 Earnings Release
2024-04-29	CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
2024-04-30	DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30	PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30	EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30	AZENTA, INC.: Q2 2024 Earnings Release (Projected)

Today	GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
Today	GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-26 01:00	BB BIOTECH AG: Q1 2024 Earnings Release
2024-04-25	BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25	PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
2024-04-25	HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
2024-04-25	BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
2024-04-25	CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 07:00	MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
2024-04-25 02:00	PURETECH HEALTH PLC: Q4 2023 Earnings Release